Mark J. Hynes

1.9k total citations · 1 hit paper
9 papers, 1.5k citations indexed

About

Mark J. Hynes is a scholar working on Oncology, Cancer Research and Hepatology. According to data from OpenAlex, Mark J. Hynes has authored 9 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Cancer Research and 2 papers in Hepatology. Recurrent topics in Mark J. Hynes's work include Cancer Cells and Metastasis (8 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Mark J. Hynes is often cited by papers focused on Cancer Cells and Metastasis (8 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Mark J. Hynes collaborates with scholars based in United States and France. Mark J. Hynes's co-authors include Emina H. Huang, Henry D. Appelman, Tao Zhang, Max S. Wicha, Gabriela Dontu, Bruce M. Boman, Christophe Ginestier, Jeremy Z. Fields, Diane M. Simeone and Jingjiang Wu and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer Research.

In The Last Decade

Mark J. Hynes

9 papers receiving 1.5k citations

Hit Papers

Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malig... 2009 2026 2014 2020 2009 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark J. Hynes United States 7 1.2k 767 502 128 113 9 1.5k
Chi Tat Lam Hong Kong 10 940 0.8× 889 1.2× 549 1.1× 107 0.8× 196 1.7× 12 1.6k
Nikolaos A. Dallas United States 13 711 0.6× 889 1.2× 451 0.9× 73 0.6× 117 1.0× 16 1.4k
Ariel Ka-Man Chow Hong Kong 16 624 0.5× 672 0.9× 440 0.9× 115 0.9× 97 0.9× 27 1.2k
Muh Hwa Yang Taiwan 6 649 0.5× 900 1.2× 753 1.5× 63 0.5× 96 0.8× 8 1.4k
Kari Fischer United States 5 945 0.8× 891 1.2× 575 1.1× 71 0.6× 148 1.3× 6 1.5k
Mileidys Perez Alea Italy 10 963 0.8× 650 0.8× 302 0.6× 133 1.0× 300 2.7× 12 1.4k
Matthew T. Harbison United States 8 924 0.8× 853 1.1× 362 0.7× 101 0.8× 136 1.2× 8 1.6k
Nikolina Radulovich Canada 22 748 0.6× 910 1.2× 415 0.8× 73 0.6× 141 1.2× 36 1.6k
María Virtudes Céspedes Spain 7 1.0k 0.9× 872 1.1× 410 0.8× 95 0.7× 240 2.1× 9 1.7k
Uta Kossatz-Boehlert Germany 14 689 0.6× 951 1.2× 333 0.7× 68 0.5× 139 1.2× 15 1.4k

Countries citing papers authored by Mark J. Hynes

Since Specialization
Citations

This map shows the geographic impact of Mark J. Hynes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Hynes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Hynes more than expected).

Fields of papers citing papers by Mark J. Hynes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Hynes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Hynes. The network helps show where Mark J. Hynes may publish in the future.

Co-authorship network of co-authors of Mark J. Hynes

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Hynes. A scholar is included among the top collaborators of Mark J. Hynes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Hynes. Mark J. Hynes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Abel, Ethan V., Edward Kim, Jingjiang Wu, et al.. (2014). The Notch Pathway Is Important in Maintaining the Cancer Stem Cell Population in Pancreatic Cancer. PLoS ONE. 9(3). e91983–e91983. 129 indexed citations
2.
Fischer, Marcus, Mark J. Hynes, Jingjiang Wu, et al.. (2012). Anti-DLL4 Has Broad Spectrum Activity in Pancreatic Cancer Dependent on Targeting DLL4-Notch Signaling in Both Tumor and Vasculature Cells. Clinical Cancer Research. 18(19). 5374–5386. 58 indexed citations
3.
Li, Chenwei, Jingjiang Wu, Mark J. Hynes, et al.. (2011). c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target. Gastroenterology. 141(6). 2218–2227.e5. 297 indexed citations
4.
Proctor, Erica, et al.. (2011). Inhibition Of The Notch Signaling Pathway Targets Cancer Stem Cells In Pancreatic Ductal Adenocarcinoma. Journal of Surgical Research. 165(2). 303–303. 1 indexed citations
5.
Huang, Emina H., Laura A. Johnson, Kathryn A. Eaton, et al.. (2010). Atorvastatin Induces Apoptosis In Vitro and Slows Growth of Tumor Xenografts but Not Polyp Formation in Min Mice. Digestive Diseases and Sciences. 55(11). 3086–3094. 19 indexed citations
6.
Li, Chenwei, Mark J. Hynes, Joseph S. Dosch, et al.. (2010). Abstract LB-257: c-Met: a new cancer stem cell marker and therapeutic target for pancreatic cancer. Cancer Research. 70(8_Supplement). LB–257. 1 indexed citations
7.
Carpentino, Joseph E., Mark J. Hynes, Henry D. Appelman, et al.. (2009). Aldehyde Dehydrogenase–Expressing Colon Stem Cells Contribute to Tumorigenesis in the Transition from Colitis to Cancer. Cancer Research. 69(20). 8208–8215. 165 indexed citations
8.
Hynes, Mark J., et al.. (2009). Review Paper: Implications of the “Cancer Stem Cell” Hypothesis on Murine Models of Colon Cancer and Colitis-associated Cancer. Veterinary Pathology. 46(5). 819–835. 8 indexed citations
9.
Huang, Emina H., Mark J. Hynes, Tao Zhang, et al.. (2009). Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis. Cancer Research. 69(8). 3382–3389. 840 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026